ARCHIVES

Five Awards Expected In Annual CCP Review; 21 Applicants Compete For Limited Funding

This article is from The Cancer Letter archive.

Vol. 17 No. 05 | February 1, 1991

Download PDF Visit The Full Archive

Related Articles

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

February 21, 2003

Funding Opportunities: HHMI Commits $300M To Support Early Career Scientists.

March 21, 2008

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

1st Cancer Patients Treated With Gene Therapy At NIH

February 1, 1991